Evaluating the Development of a Palliative Care Consultation Algorithm for Inpatient Bone Marrow Transplant Patients by Capps, Nicole
  
 
EVALUATING THE DEVELOPMENT OF A PALLIATIVE CARE CONSULTATION 
ALGORITHM FOR INPATIENT BONE MARROW TRANSPLANT PATIENTS 
 
 
 
Nicole A. Capps 
 
 
 
A project submitted to the faculty at the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Doctorate of Nursing Practice in the Doctor of 
Nursing Practice Program in the School of Nursing. 
 
 
 
 
 
Chapel Hill 
2017 
 
 
 
 
          Approved by: 
          Deborah K. Mayer 
          Meg Zomorodi 
          Kimberly A. Wehner 
 
 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2017 
Nicole A. Capps 
ALL RIGHTS RESERVED 
 
 
 
 
 iii 
 
 
 
 
 
ABSTRACT 
Nicole A. Capps: Evaluating the Development of a Palliative Care Consultation Algorithm for 
Inpatient Bone Marrow Transplant Patients 
(Under the direction of Deborah K. Mayer) 
 
Bone marrow transplant patients often experience increased symptom burden and 
decreased quality of life due to intense therapy regimens needed for disease treatment.  Palliative 
care services have been shown to improve patient’s quality of life and decrease symptom burden.  
In the acute care setting, the primary method to initiate palliative care is through consultation.  
Palliative care services are often underutilized in the inpatient bone marrow transplant setting 
due to clinical practice barriers including provider resistance, inadequate knowledge regarding 
palliative services, or misunderstanding which patients may benefit from palliative care.  Current 
oncology recommendations and accrediting organizations support incorporating palliative care 
into patients’ plans of care.  A current gap exists between evidence-based recommendations 
supporting palliative care use in oncology patient care and clinical practice.  This project 
developed a palliative care consult algorithm specific to inpatient bone marrow transplant 
patients to help clinicians best determine which patients may benefit from palliative care 
services.  
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CHAPTER 1: INTRODUCTION 
Background and Significance 
Palliative care has been shown to improve patient and caregiver quality of life, decrease 
disease symptomology, and even prolong lifespan (NCCN, 2013; Temel, et al., 2010; Bakitas, et 
al., 2009; Cassarett, et al., 2008).  A number of organizations have identified and endorsed the 
importance of palliative care including the Institute of Medicine (IOM), The National 
Comprehensive Cancer Network (NCCN), and The Joint Commission (Glare & Chow, 2014; 
IOM, 2014; Weincke & Coyne, 2014).  Additionally, the Centers for Medicare and Medicaid 
Services (CMS) and the Affordable Care Act (ACA) consider palliative care a measurable 
patient quality outcome that must be incorporated in appropriate patient’s care (NCP, 2013).  
Unfortunately, even with the strong evidence recommending and supporting palliative care, 
palliative care consults are underutilized in health care, denying appropriate patients and their 
families the benefits of this service (Bernacki, et al., 2012).  The underutilization is often due to 
clinical practice barriers and provider resistance, resulting from lack of palliative care knowledge 
or the misunderstanding of its appropriate use in patient care (Morikawa, Shirai, Ochiai, 
Miyagawa, 2015; Bernacki, et al., 2012; Weissman & Meier, 2011; Bakitas, et al., 2009).   
Problem Statement 
Patients needing bone marrow transplants as cancer treatment require intense 
myeloablative chemotherapy regimens and prolonged treatment courses.  These patients can 
experience debilitating side effects including nausea, vomiting, diarrhea, fatigue, infection, 
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mucositis, and pain, often needing extensive symptom management (Selvaggi, et al., 2014).  The 
aggressive treatment and consequent side effects negatively impacts patients’ quality of life.  
Palliative care interventions have been shown to improve some oncology patients’ 
symptomology, quality of life, and overall disease course (Ferrell, et al., 2016; Bauman & 
Temel, 2014; Wiencke & Coyne, 2014; NCCN, 2013; Temel, et al., 2010; Bakitas, et al., 2009; 
Casarett, et al., 2008; Milberg, 2007; Jack, Hillier, Williams & Oldham, 2006).  The most 
common method of palliative care delivery is through consultation services, meaning the primary 
medical team consults the palliative care service to provide insight on certain patients’ care 
(Weissman & Meier, 2011).  A palliative care consult allows a member of the palliative care 
team to discuss palliative services and interventions with patients and families, and potentially 
become part of the medical care team (Weissman & Meier, 2011).  The palliative care service 
also offers recommendations to the primary medical team of alternative or additional 
interventions to provide comprehensive patient care.  
Regrettably, palliative care consults are underutilized in the inpatient bone marrow 
transplant setting due to a myriad of factors including primary teams’ preference to manage their 
own patients and hesitancy to order consults, general provider misunderstanding of palliative 
services, or the common misconception that palliative care equates hospice (Morikawa, Shirai, 
Ochiai, Miyagawa, 2015; Bernacki, et al., 2012; Weissman & Meier, 2011; Bakitas, et al., 2009).  
Lack of or delay in palliative care consults for inpatient bone marrow transplant patients denies 
them a beneficial service that could improve their symptom management and overall quality of 
life (Morikawa, Shirai, Ochiai, Miyagawa, 2015; Weissman & Meier, 2011; Temel, et al., 2010).  
A gap exists between best evidence practice recommendations and actual clinical practice in 
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regards to implementing palliative care.  It follows that a clinical intervention is needed to help 
clinicians recognize when to initiate palliative care consults and potentially reduce this gap.  
Purpose Statement 
The purpose of this DNP project was to develop and implement a palliative care consult 
algorithm for inpatient bone marrow transplant clinicians to use in identifying those patients who 
could benefit from palliative care and to increase palliative care consults.  By using this 
algorithm, providers had objective criteria to use in referring patients to palliative care and 
increase utilization of this service.  A secondary purpose of the project included documenting the 
specific interventions implemented by inpatient bone marrow transplant providers to manage 
patients’ symptom burden.  This list of specified symptom management interventions was 
collected to further understand what interventions were already used by inpatient bone marrow 
transplant providers and perhaps explain why palliative care consults may be lower in the 
specialized inpatient bone marrow transplant setting.  
Research Questions 
1. How does the implementation of a palliative care algorithm impact the number of 
palliative care consults on a bone marrow transplant unit?   
2. What interventions occur by the bone marrow transplant clinicians, preventing them 
from initiating a palliative care consult, if the algorithm deems it appropriate?   
3. What changes or suggestions should be made to the palliative care algorithm, if any, 
as offered by feedback from the inpatient bone marrow transplant clinicians?  
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CHAPTER 2: REVIEW OF LITERATURE 
Review of Literature 
 The benefits of palliative care services have been well documented in the literature with 
gains impacting the patient, family, caregivers, hospitals, health care providers, and overall 
health care system economics (El-Jawahri, et al., 2016; Perrin & Kazanowski, 2015; Bernacki, et 
al., 2012; Temel, et al., 2010; Bakitas, et al., 2009; Casarett, et al., 2008).  Patients report 
improved quality of life, increased life span, shorter hospital stays, and overall decreased health 
care costs as a result of palliative care services and interventions (Perrin & Kazanowski, 2015).  
However, even with the documented improved outcomes, palliative care continues to be 
underutilized, thus depriving patients of a service from which they would benefit.  A disconnect 
exists between evidence of palliative care benefits and providers incorporating it into clinical 
practice, with providers often reluctant to initiate consults (Bakitas, et al., 2009).  Interventions 
must occur on the provider level to help increase use of this service (Weissman & Meier, 2011).   
Quality care and symptom management improvement is needed for patients facing 
terminal or chronic illnesses (El-Jawahri, et al., 2016).  Patients with chronic and terminal 
diagnoses report unmet needs from their primary medical team including decreased quality of 
life and poor symptom management related to chronic pain, fatigue, and psychosocial issues 
(Bugová, Hajnová, Sikorová, & Jaroová, 2014).  Some literature suggests that providers focus 
mostly on lifesaving interventions and bypass assessing patients’ psychosocial needs and disease 
symptoms (Perrin & Kazanowski, 2015).   
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Palliative care provides a specialty consult service that has the ability to address care gaps 
in traditional medicine by focusing on the physical, psychosocial, and spiritual needs of patients 
that often go unmet (Bauman & Temel, 2014; Bugová, Hajnová, Sikorová, & Jaroová, 2014; 
Bakitas, et al., 2009).  This holistic view often differs from the curative medical model and 
allows for more comprehensive care of the patient.  It is from this unique care approach that 
palliative care has been shown to improve overall care quality for patients and caregivers 
(Bauman & Temel, 2014; Bernacki, et al., 2012).  As stated, palliative care teams offer holistic 
care interventions, including pain management, care planning, and antidepressant therapies, that 
have been shown to improve quality of life, symptom management, and consider the patient’s 
treatment goals (Bugová, Hajnová, Sikorová, & Jaroová, 2014; Bakitas, et al., 2009; Casarett, et 
al., 2008).  
Multiple barriers inhibit palliative care consults from occurring.  These include providers 
delaying referrals until late in the disease course, not referring to the service in general, 
misunderstanding palliative care and the services it entails, inaccurate association of palliative 
care with end-of-life and hospice care, difficulty recognizing appropriate patients for palliative 
care services, and lack of collaboration between the patient’s medical team and palliative care 
services (Morikawa, Shirai, Ochiai, Miyagawa, 2015; Glare & Chow, 2014; Weissman & Meier, 
2011; Bakitas, et al., 2009).  
As stated, primary medical teams are often reluctant to initiate palliative care consults.  
The culture of the health care organization and relationship between service lines may impact 
whether consults occur (Morikawa, Shirai, Ochiai, Miyagawa, 2015; Rocque, et al., 2015).  
Some research suggests providers may not consult palliative care services due to personal 
confidence in their own medical knowledge and ability to care for their patients alone, denying 
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the need of collaboration with other services (Morikawa, Shirai, Ochiai, Miyagawa, 2015).  
Additionally, medical teams may associate a palliative care consult as insinuating they are unable 
to provide appropriate care for their patients (Morikawa, Shirai, Ochiai, Miyagawa, 2015; 
Rocque, et al., 2015).  Culture change and provider education may be needed for palliative 
collaboration to be considered into a comprehensive treatment or care plan (Rocque, et al., 
2015).  
Some providers have difficulty determining which patients are suitable for palliative care 
consults and services (Perrin & Kazanowski, 2015; Rhodes, et al., 2015; Bugová, Hajnová, 
Sikorová & Jaroová, 2014; Glare & Chow, 2014).  As providers are the ones who initiate 
consults, they must be able to determine appropriate patients who could benefit from palliative 
care (Perrin & Kazanowski, 2015; Bugová, Hajnová, Sikorová & Jaroová, 2014).  Unfortunately, 
many providers lack the necessary education and knowledge of palliative care, the services 
offered, or when best to initiate a consult (Morikawa, Shirai, Ochiai, Miyagawa, 2015).  Absence 
of palliative care curriculum in medicine and advanced practice nursing education curriculum 
can prevent providers from having necessary palliative care assessment skills and knowledge 
(Weissman & Meier, 2011).  Additionally, limited availability of clinical palliative care 
evidence-based assessment algorithm tools further inhibits providers’ ability to appropriately 
recognize which patients need palliative care (Rhodes, et al., 2015; Glare & Chow, 2014; 
Weissman & Meier, 2011).  Without appropriate tools, providers base consult criteria on 
subjective assessments without objective indicators for when palliative care would be 
appropriate (Rocque, et al., 2015; Rhodes, et al., 2015; Glare & Chow, 2014).  This, together 
with lack of palliative care education, inhibits providers from knowing when it is suitable to 
initiate consults.  For palliative services to improve the quality of patient care, providers must 
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have the skills and resources to assess and determine appropriate patients for palliative care 
consults.  Fortunately, palliative care training programs have increased over the last decade as 
many health provider education programs have incorporated palliative care into curriculum 
(Wiencek & Coyne, 2014; Weissman & Meier, 2011).  Additionally, national guidelines for 
quality patient care recommendations, interprofessional educational offerings, research 
endeavors, and palliative care resources have also increased (Grant, Elk, Ferrell & von Gunten, 
2009).  By expanding palliative care educational opportunities and supporting its use clinically, 
the utilization of palliative care should continue to increase (Grant, Elk, Ferrell & von Gunten, 
2009).  
Palliative care is often misunderstood and incorrectly associated with end-of-life or 
hospice care (Morikawa, Shirai, Ochiai, Miyagawa, 2015).  Palliative care does not mean 
treatment cessation; rather it can coincide with treatment interventions by the primary medical 
team (Bauman & Temel, 2014).  Whereas hospice helps patients and families cope with end-of-
life and dying, palliative care strives to reduce suffering, and help patients and families cope with 
their illness at any stage (Morikawa, Shirai, Ochiai, Miyagawa, 2015).  Palliative care is not 
about treating the cancer itself, but offers another means to help manage the symptom burden 
and distress it causes.  The medicalization of dying suggests the dichotomy of care, that patients 
either receive curative care or are dying, with no option between (Milberg & Strang, 2007).  This 
dichotomous view of medical care and treatment contributes to the inaccurate association that 
palliative care must occur only at time of death (Milberg & Strang, 2007).  Providers must 
understand that palliative care can occur with curative treatment and does not mean death or 
hospice (Morikawa, Shirai, Ochiai, Miyagawa, 2015; Milberg & Strang, 2007).  Even when 
providers acknowledge the difference between palliative care and hospice, patients and families 
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may associate palliative care with hospice, further preventing providers from initiating consults 
(Morikawa, Shirai, Ochiai, Miyagawa, 2015).  Many patients and families do not understand 
exactly what palliative care entails or the services offered (Morikawa, Shirai, Ochiai, Miyagawa, 
2015).  From this, it appears that palliative care education is necessary not only for all health care 
providers, but also patients and families (Rocque, et al., 2015).   
Due to the misconception that palliative care equates with hospice, consults often occur 
late in the disease or illness trajectory, or not at all (Perrin & Kazanowski, 2015).  Some 
evidence suggests palliative care is often not considered until the last three months of a patient’s 
life (Perrin & Kazanowski, 2015).  This delay impacts overall patient care and outcomes, as 
patients and caregivers report greater satisfaction of care and improved symptomology with 
earlier consults and interventions (El-Jawahri, et al., 2016; Temel, et al., 2010).  Research 
supports that earlier palliative care consults result in greater symptom management and increased 
quality of life (Perrin & Kazanowski, 2015).  Palliative care can be initiated at any point in the 
illness trajectory and can occur with or independent of curative or life-prolonging treatment 
(Bauman & Temel, 2014; NCP, 2013).  This follows palliative care may intervene at any stage 
from diagnosis until death (El-Jawahri, et al., 2016; Perrin & Kazanowski, 2015).  As stated, the 
earlier palliative care intervenes, the greater benefits and outcomes for patients and caregivers 
(El-Jawahri, et al., 2016; Perrin & Kazanowski, 2015; Temel, et al., 2010).  
The aging of the general population also impacts the need for palliative care consults. 
People are living longer with more chronic illnesses and disease, and the health care system must 
meet the care demands of the aging population.  As the population ages, the number of chronic 
and terminal diagnoses have increased necessitating greater need for and understanding of 
palliative care services (Grant, Elk, Ferrell & von Gunten, 2009).  Care management of chronic 
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and terminal illnesses has become more complex requiring multiple disciplines to provide patient 
care (Bauman & Temel, 2014; Bernacki, et al., 2012).  Additionally, comprehensive patient care 
has become the recommended care model for chronic and terminally ill patients (Morikawa, 
Shirai, Ochiai, Miyagawa, 2015).  This comprehensive care model necessitates a medical model 
culture change that encompasses holistic and palliative care, in addition to curative therapy 
(Morikawa, Shirai, Ochiai, Miyagawa, 2015).  These changes in disease acuity and course, and 
inclusion of comprehensive care models suggest that palliative care services will continue to rise 
(NCP, 2013).   
The barriers inhibiting palliative care consults must be overcome to meet the demand for 
this specialty service (Weissman & Meier, 2011).  The growing palliative care need necessitates 
providers improving their comfort and awareness for initiating palliative services (Weissman & 
Meier, 2011).  Providers must further their education, comfort, and assessment skills with 
palliative care to incorporate it into their treatment and care plans (Weissman & Meier, 2011; 
Grant, Elk, Ferrell & von Gunten, 2009). 
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CHAPTER 3: CONCEPTUAL / THEORETICAL FRAMEWORK 
Theoretical Framework 
The ecological systems theory provides a novel way of understanding the problem of 
underutilization of palliative care consults for inpatient bone marrow transplant patients.  This 
problem results from various systems and interactions that are explained using the ecological 
systems theory.  The ecological systems theory focuses on the individual and the multi-leveled 
surrounding environments that form the personal ecosystem (Bronfenbrenner, 1979).   
Ecological systems theory describes interactions that occur within and between different 
environments (Bronfenbrenner, 1979).  The theoretical framework serves to understand and 
organize information about individuals, the interconnectedness of their environments, and how 
this influences outcomes (Bronfenbrenner, 1979).  
In order to understand why palliative care consults are not occurring in the inpatient 
setting, the ecological systems theory must be expanded to include the health organization 
systems.  The health organization ecological system framework incorporates both 
Brofenbrenner’s ecological systems theory and its applicability to healthcare organizations, as 
presented in Hancock and Perkins’ framework titled Mandala of Health (CCSDH, 2015; 
Bronfenbrenner, 1979).  Per the ecological systems theory, there are five distinct environments 
surrounding the individual (as shown in the diagram presented in Appendix A) (Bronfenbrenner, 
1979).  The five environmental levels described in the ecological systems theory include the 
microsystem, mesosystem, exosystem, macrosystem, and chronosystem (Bronfenbrenner, 1979).  
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These environmental system levels exist within the ecosystem as their own environments while 
also interacting with other systems and influencing outcomes (Bronfenbrenner, 1979).  The 
center of this system is the individual bone marrow transplant patient who needs a palliative care 
consult.  The microsystem describes the innermost relationships with the patient including 
family, friends, colleagues, and medical providers.  The mesosystem presents the interacting 
relationships between the participants of the microsystem, such as that between the family and 
health care provider.  The exosystem describes indirect influences of the ecological system that 
impacts the patient and outcomes without having direct contact with the patient (Wang, Burns & 
Watts, 2010).  For example, organizational factors and differing service provider politics may 
impact whether a palliative consult occurs.  The macrosystem presents broader community 
factors and can include the culture of the organization (Wang, Burns & Watts, 2010).  In 
medicine, this involves the curative culture of medicine and the value that providers place on 
curative treatments.  The chronosystem constantly evolves and influences the ecosystem as time 
passes and the patient transitions through care.  Understanding the chronosystem of the patients’ 
illness trajectory presents multiple areas for palliative care to occur.  Care transitions include 
events such as diagnosis, increased symptom burden, and death.  Palliative care consults may 
occur at any time throughout the illness.  These systems have bidirectional relationships between 
levels with the outer environments able to impact the inner environments and vice versa.  Use of 
the ecological systems theory and applying it to health care organizational structures presents 
multiple determinants that influence the barriers and problem of underutilization of palliative 
care consults.   
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CHAPTER 4: PROJECT DESIGN & METHODOLOGY 
Project Design 
 This descriptive, quality improvement interventional project developed a palliative care 
consult algorithm specific to hospitalized inpatient bone marrow transplant patients and 
evaluated whether its use influenced palliative care consult rates.  The project reviewed a 
comprehensive palliative care database and identified specific palliative care consult criteria used 
for bone marrow transplant patients.  The project also presents specialized symptom 
management interventions currently used by the inpatient bone marrow transplant medical team 
to specifically manage the unique symptoms of this particular patient population.  
Palliative Care Consult Algorithm Development   
For this project, the palliative care consult algorithm for inpatient bone marrow transplant 
patients used specialized objective criteria to help clinicians identify hospitalized bone marrow 
transplant patients appropriate for palliative care consults.  The developed palliative care consult 
algorithm consists of ten-item criterion specific to inpatient bone marrow transplant patients.  
Each individual criterion has allotted points that added together provide a total score suggesting 
to providers whether a palliative care consult may be necessary.   
The project algorithm was developed by modifying the validated NCCN palliative care 
screening guidelines to be more particular to inpatient bone marrow transplant patients, 
evaluating a palliative care database to determine detailed palliative care consult criteria specific 
to bone marrow transplant patients, and from the expert opinions of bone marrow transplant 
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clinicians.  The NCCN palliative care screening guidelines were developed from a panel of 
oncology experts and have been tested, modified, and validated by other organizations, including 
the American Society of Clinical Oncology and Memorial Sloan Kettering Cancer Center (Glare 
& Chow, 2015; Glare, et al., 2013).  Therefore, these palliative care screening guidelines seemed 
appropriate to use as the foundation in developing the palliative care algorithm for this project.  
As stated, a comprehensive historical palliative care database, maintained at the academic 
medical center and project site, was accessed to review prior bone marrow transplant patient 
cases consulted to palliative care.  A total of eight palliative care consults occurred for bone 
marrow transplant patients during the previous five years of recorded data at the project site 
(2010-2015).  This database review provided the specific consult criteria used for these previous 
bone marrow transplant patients and was included into the algorithm.  Expert bone marrow 
transplant clinician opinion and palliative care provider input were also instrumental in 
developing this algorithm specific to the hospitalized bone marrow transplant patient population; 
as each specialty could offer insight on what criteria to include.  
Algorithm Implementation Process Design  
The project implementation necessitated access to an inpatient bone marrow transplant 
unit where patients could be evaluated using the developed palliative care algorithm.  The project 
intervention required inpatient bone marrow transplant nursing staff incorporating the palliative 
care algorithm into their clinical practice.  The nurses used the developed inpatient bone marrow 
transplant palliative care consult algorithm to assess each of their assigned patients with the 
specified algorithm criteria and scored each patient based on their individualized symptoms and 
needs.  Each algorithm completed on a patient provided a total palliative care algorithm score.  If 
the score suggested a patient was appropriate for a palliative care consult (an algorithm score 
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>5), then the total score and completed algorithm were given to the charge nurse to present to the 
inpatient bone marrow transplant providers during patient rounds.  The algorithms scoring 
greater than five were then discussed by the inpatient bone marrow transplant team during 
medical patient rounds to further evaluate whether a palliative care consult, or other intervention, 
were needed. 
Algorithm Scoring.  For the purpose of this project, a palliative care algorithm score of 
greater than 5 is considered a positive screen and suggests a palliative care consult (Glare & 
Chow, 2014).  A score of greater than 5 was determined appropriate for a positive screen because 
it indicates the patient met at least two of the screening criteria, and that further symptom 
management discussion was needed by the inpatient bone marrow transplant medical team.  If 
the algorithm score total did not determine a patient as appropriate for a palliative consult (score 
<5), a consult did not occur.  However, patients could be reassessed again if they were still 
admitted to the inpatient bone marrow transplant unit, their status changed, their algorithm score 
increased, or a family member or patient requested a palliative care consult.  
Identification of Project Stakeholders   
Determination and inclusion of project stakeholders was fundamental for this project’s 
success.  The project lead, also the principal investigator for the project and author of this paper, 
recognized identifying key team members and stakeholders as necessary to achieve buy-in of the 
project and allow continued utilization of the algorithm.  Stakeholders were identified as those 
individuals who had expert knowledge in either bone marrow transplantation or palliative care, 
since they offered input and feedback on the algorithm development and throughout the project 
implementation.  Stakeholders were also included who could be instrumental in the continued 
clinical use of the palliative care consult algorithm, even after completion of this project.  The 
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project lead recognized for this project to have continued utility on the unit and be part of clinical 
practice change, these vested stakeholders must be identified.  
Stakeholders included the bone marrow transplant medical director, bone marrow 
transplant nurse manager, palliative care service providers, and other bone marrow transplant 
clinicians including attending physicians, oncology fellows, advanced practice providers (NPs 
and PAs), pharmacists, and nurses.   
Stakeholder input was obtained prior to the project implementation to help create and 
modify the algorithm; in addition to discuss the project implementation process before it began.  
The project lead also desired clinician feedback throughout project implementation to guarantee 
the algorithm was both meeting its clinical function and adequately assessing the needs of the 
bone marrow transplant patients.  Therefore, a feedback survey was sent to inpatient bone 
marrow transplant clinicians three weeks after the initial project implementation trial period, and 
then again at project completion.  The two feedback surveys allowed clinicians to provide input 
or suggestions to the algorithm tool or implementation process.  The feedback surveys assessed 
stakeholders’ feedback on utilization of the algorithm, ease of use, the length of time the 
algorithm took to complete, and what changes (if any) they would make to the algorithm.   
Symptom Management Interventions 
As previously stated, the project also allowed for a secondary intervention of detailing 
and documenting specific symptom management interventions implemented by the inpatient 
bone marrow transplant medical team for those patients who screened positive on the algorithm 
but did not receive a palliative care consult.  Of note, bone marrow transplant involves a 
specialized service of patients with unique symptom presentation and interventions, which may 
differ from other hospital services and patient populations.  Due to the specialized nature of 
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symptom presentation and unique management, the bone marrow transplant team primarily and 
exclusively manages bone marrow transplant patients during their treatment course and 
throughout hospital admission.  The unique symptom presentation and interventions specific to 
bone marrow transplant may help explain why palliative care consults are underutilized in the 
bone marrow transplant patient population.  Therefore, it was important to assess what 
interventions the bone marrow transplant providers initiate, as this data has not been previously 
recorded and must be considered when evaluating the use of palliative care services with bone 
marrow transplant patients. 
It was actually during an educational meeting for this project that this secondary 
intervention was developed.  Some bone marrow transplant providers suggested a reason that 
bone marrow transplant palliative care consult rates may be less than the number of consults with 
other hospital services is because bone marrow transplant patients have unique symptom 
presentations and required specialized interventions, best known by the bone marrow transplant 
providers.  They argued that palliative care services might not be needed if bone marrow 
transplant providers were able to manage the patient’s specific bone marrow transplant 
symptoms.  Therefore, it was decided if a palliative care consult was not initiated by the bone 
marrow transplant medical team for patients with positively screened algorithms, that the team’s 
recommended intervention would be recorded to document specific interventions the team 
already provides.  This data could help further explain or justify the underutilization of palliative 
care consults for this specialized group of patients.   
Methodology 
The project intervention occurred on a 24-bed inpatient bone marrow transplant 
Foundation for the Accreditation of Cellular Therapy (FACT) recognized unit at a large 
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academic medical and National Cancer Institute designated comprehensive center located in 
Chapel Hill, North Carolina.  The institutional review board (IRB) and nursing research council 
(NRC) approved the project at the site prior to the palliative care database review and 
implementation of the project algorithm.   
Meeting with Stakeholders 
Prior to implementation, the project lead met with key stakeholders of this quality 
improvement project, including the bone marrow transplant medical director, palliative care 
providers, bone marrow transplant medical providers, the inpatient bone marrow transplant nurse 
manager, and inpatient bone marrow transplant nurses, to discuss the basis of the project, the 
algorithm intervention, and the project timeline.  The bone marrow transplant nurse manager and 
bone marrow transplant medical director supported the implementation of the palliative care 
algorithm, use of nursing staff and resources to assess patients and complete the algorithm, and 
having the project lead round with the medical team during patient rounds.  The project lead 
consulted members of the palliative care team to discuss the project, incorporate their expert 
insight into revising the NCCN palliative care recommendations, and gain access to the palliative 
care database maintained at the academic medical center.  The project lead also met with a bone 
marrow transplant attending physician, interested in transplant symptom management, who also 
helped coordinate the algorithm implementation with medical team providers.   
Palliative Care Consult Algorithm Development 
 NCCN Palliative Care Screening Guidelines.  The palliative care consult algorithm 
was developed by modifying the NCCN palliative care screening guidelines to include specific 
bone marrow transplant palliative care consult criteria data, obtained from a comprehensive 
palliative care database, and expert bone marrow transplant clinician opinion.  The developed 
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inpatient bone marrow transplant palliative care algorithm followed the general outline of the 
validated NCCN palliative care screening guidelines for patients with advanced cancer (Glare & 
Chow, 2015; NCCN, 2013).  However, certain criteria on the NCCN screening tool was not 
applicable to the BMT patient population, and needed modification.  Therefore, for this project 
and algorithm development, the NCCN palliative care screening guidelines were modified to 
consider data gathered from the palliative care database chart reviews and also include bone 
marrow transplant provider expert opinion.  
Palliative Care Database.  As stated, the academic medical center and project site 
maintains a historical database of prior palliative care consults that occurred in the medical 
center.  The palliative care database includes information such as patient demographics, 
diagnoses, palliative care consult criteria, length of disease, disease symptoms, hospital service 
line, and any palliative care recommendations or interventions.  A total of eight bone marrow 
transplant patients were consulted between 2010-2015 (over 60 months) and these charts were 
accessed and reviewed.  From the chart review, data were extracted to determine the specific 
criteria used for initiating the palliative care consults for these eight bone marrow transplant 
patients.  This data helped define necessary criteria used to adapt the NCCN palliative care 
screening guidelines to be more specific to bone marrow transplant patients.  Together, the 
modified NCCN palliative care screening guidelines and consult criteria specific to bone marrow 
transplant patients retrieved from the palliative care database, outlined the initial version of the 
inpatient bone marrow transplant palliative care consult algorithm. 
Expert Opinion.  The project introduction and initial proposed inpatient palliative care 
algorithm were presented during both the inpatient bone marrow transplant nursing and medical 
provider monthly meetings.  During these meetings, expert clinician input was offered on the 
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algorithm, and changes were made to the initial draft based on these suggestions.  A second draft 
of the algorithm was sent via email to bone marrow transplant clinicians allowing another 
opportunity for additional input on the algorithm.  An updated final and third version, 
incorporating all suggested modifications, was approved by the bone marrow transplant medical 
director and again sent via email to the project stakeholders.  The final algorithm version was 
also presented at another bone marrow transplant nursing staff meeting and bone marrow 
transplant provider research meeting prior to project implementation. 
Initial Algorithm Criteria – Draft 1 
The initial algorithm (Draft 1) shown in Appendix B consisted of twelve criterion 
including:  
• Initial bone marrow transplant consult within previous 4 months (2 points) 
• Functional status of patient (Karnofsky Performance Scale)* (0-2 points) 
• Serious transplant-related complications (hemorrhagic cystitis, GVHD – grade IV, 
VOD, CMV, BK) (1 point) 
• Significant physical or psychosocial comorbidities (i.e., depression, anxiety, 
hypertension, diabetes, chronic obstructive pulmonary disease, chronic kidney 
disease, or heart failure (1 point)  
• Other issues complicating care (1 point) 
• Uncontrolled symptoms (pain, n/v) (1 point) 
• Moderate-to-severe distress related to cancer diagnosis and treatment (1 point) 
• Patient / family concerns related to care / decision-making (1 point) 
• Patient / family requests consult (5 points) 
• Prolonged length of hospital stay (1 point) 
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• Frequent hospital readmissions (>1 since BMT discharge) (1 point) 
As stated, adjustments were made from the initial version of the algorithm based on the 
feedback and input provided from the project stakeholders, including bone marrow transplant 
physicians, bone marrow transplant advanced practice providers, bone marrow transplant 
pharmacists, bone marrow transplant nurses, and the DNP project chair.  
Algorithm Refinement – Draft 2 
The adjustments made between the initial algorithm draft and the second version (draft 2 
shown in Appendix C) were based on the following considerations listed below.   
• The criteria point initially allotted for patients needing an “initial bone marrow 
transplant consult within the previous 4 months” was removed due to the 
subjective nature of whether need for a bone marrow transplant was considered a 
positive or negative event by the patient.  Additionally, the lack of evidence and 
validation for this point ended in it being excluded from the final version.   
• The “functional status of patient” criteria was expanded to include both ECOG 
and Karnofsky scores, as both functional performance scoring system are used to 
assess bone marrow transplant patients’ functional status at the project site 
academic center and other bone marrow transplant programs.  The scoring point 
breakdown was also delineated on the final version so that the providers and 
nurses knew how many points to allot on the algorithm based on the Karnofsky 
and ECOG scale.  
• Further definition of the criteria “other issues complicating care” were expanded 
to include financial concerns and lack of support, to give objective measures that 
could be scored and not subjectively guessed.   
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• “Uncontrolled symptoms” were also expanded to include diarrhea and 
constipation, in addition to nausea, vomiting and pain.   
• “The moderate-to-severe distress related to cancer diagnosis and treatment” was 
clarified to mention the NCCN cancer distress screening score as the objective 
screening tool to use for scoring.  The initial algorithm version has a score >6 
necessitating a point being given for this item.  Since this screening tool was 
currently used at the academic medical center project site, bone marrow transplant 
nurses and patients were familiar with the tool and screening criteria.   
• A blank line was added to allow the nurse completing the algorithm to write their 
name so the project lead knew which nurse completed the algorithm, in case there 
was need to contact nurses for questions regarding individual algorithms or 
inconsistent scoring.   
• Additionally, a blank space was added for the name of the bone marrow transplant 
attending on service.  This was also done for the project lead to recognize 
providers who had questions or concerns regarding the algorithm, and to 
document any preferred symptom management interventions.  
This second draft of the algorithm was sent to stakeholders via email allowing them the 
opportunity to suggest additional modifications to the developed algorithm.  
Algorithm Refinement – Final Draft 
As shown below, there were minimal changes made between the second and final version 
of the algorithm.  
• The only criteria change involved “the moderate-to-severe distress related to 
cancer diagnosis and treatment” point.  The palliative care algorithm was edited 
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to allow the cancer distress screening score to match the NCCN cancer distress 
screening score, with a score >4 (it was previously noted as >6), necessitating a 
score of 1 point on the algorithm.  This was based on the current scoring and 
recommendations of the NCCN (NCCN, 2014).  
The algorithm was reformatted to allow all information to be documented on one sheet, 
allowing ease of use.  Ten criterion were used to formulate the final version of the algorithm 
(shown in Appendix D) and include:  
• Functional status of patient (using Karnofsky Performance Scale or comparable 
ECOG score) (0-2 points) 
• Serious transplant-related complications (including hemorrhagic cystitis, GVHD – 
grade IV, veno-occlusive disease (also referred to as sinusoidal obstruction 
syndrome), cytomegalovirus, BK virus) (2 points) 
• Significant physical or psychosocial comorbidities such as depression, anxiety, 
hypertension, diabetes, chronic obstructive pulmonary disease, chronic kidney 
disease, or heart failure (1 point) 
• Other issues complicating care, including financial concerns (1 point) 
• Lack of support (1 point) 
• Uncontrolled symptoms involving pain, nausea, vomiting, diarrhea, constipation 
(1 point) 
• Moderate-to-severe distress related to cancer diagnosis or cancer therapy (1 point) 
• Patient/family concerns related to care/decision-making (1 point) 
• Patient/family requests consult (5 points) 
• Prolonged length of hospital stay greater than one month (1 point) 
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• Frequent hospital readmissions defined as having more than one readmission 
since initial BMT discharge (1 point) with a total score ranging from 0-16 (Glare 
& Chow, 2014; NCCN, 2013).   
Functional Screening Scales and NCCN Distress Screening Tool.  The functional 
performance status of patient (Karnofsky Performance Scale) score was determined as follows: 
Karnofsky scale total 80-100 allotted 0 points, Karnofsky scale of 60-79 resulted in 1 point, and 
any Karnofsky scale totaling less than 60 resulted in a score of 2 points on the algorithm.  Of 
note, this follows the similar point allocation of the ECOG functional assessment and allows for 
comparable scoring between the two on the algorithm, if needed (ECOG-ACRIN, 2016).  
Additionally, the moderate-to-severe distress related to cancer diagnosis and treatment was 
determined using the validated NCCN Cancer Distress screening tool (NCCN, 2016).  A score of 
greater than four on the NCCN Cancer Distress screening thermometer resulted in one point on 
the palliative care algorithm, as a score of greater than four was determined as moderate-to-
severe distress and necessitated further provider intervention per NCCN recommendations 
(NCCN, 2014).   
Algorithm and Project Implementation Education 
All stakeholders were provided education on the purpose of developing this quality 
improvement project; the evidence supporting increased use of palliative care in the clinical 
setting, and the current gap between best practice recommendations for oncology care and actual 
clinical practice.  Stakeholders were informed of the algorithm development process and their 
role in the project implementation.  Bone marrow transplant clinicians were also educated about 
the specific inpatient palliative care algorithm consult criteria and need for bi-weekly data 
collection.  Teaching points also included how to score the algorithm, specifics for presenting the 
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algorithm during patient rounds, directions of what to do with positively (and negatively) 
screened algorithms, the necessity of documenting medical interventions if a palliative care 
consult did not occur, and how to contact the project lead with any concerns or questions.   
The nursing staff was initially educated about the algorithm during their monthly staff 
meeting the month prior to implementation, and education was reinforced by the project lead via 
email and later monthly staff meetings throughout the timeline of project implementation.  The 
purpose of the continuous education and contact was to clarify any questions or concerns related 
to the algorithm, scoring criteria, or the project implementation, in general.  The nursing staff 
was given a three-week trial period to practice using the algorithm and present any questions or 
concerns they had with the process. 
The nursing staff was also aware that during the first three weeks of the project 
implementation, the project lead would send staff reminders via email to complete the algorithms 
on Wednesday and Sunday nights.  These regular email reminders were to stop after the initial 
three-week project implementation trial, as was explained during the education sessions.  The 
reason was to reduce the project lead presence and decrease reminders so the algorithm 
completion could become part of the nursing culture and practice.  The project lead emphasized 
the importance of the nurses taking ownership of the project and implementing it as part of their 
clinical practice, without needing the presence of the project lead. 
Project and Algorithm Implementation Process 
The project implementation occurred over a three-month time period (October 2016 – 
December 2016) on the inpatient bone marrow transplant unit.  The algorithms were completed 
bi-weekly on Sunday and Wednesday night shift to allow for consistency and adequate time 
lapse for patient status and symptom presentation to change.  Algorithms were not completed 
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daily due to a concern raised by stakeholders that clinicians may become fatigued of the process 
and stop completing the project if algorithms were needed daily for every patient.  Therefore, it 
was decided that algorithms should be completed on a bi-weekly schedule.  Additionally, Sunday 
and Wednesday night shift were chosen because the bone marrow transplant medical team 
develops weekly patient plans-of-care on Mondays.  This bi-weekly schedule allowed the current 
palliative care algorithm score to be available during Monday rounds and part of these plans-of-
care discussions.  
Nursing Role.  The project lead selected the primary nurse to complete the algorithm on 
their assigned patients, opposed to the bone marrow transplant medical team, as they were 
deemed most aware of patients’ current symptom burden and knowledgeable of algorithm 
scoring.  A concern the bone marrow transplant medical team discussed prior to project 
implementation was that patient rounds were already time consuming, and they worried the 
algorithm would significantly lengthen and burden their daily patient rounding time.  To 
maintain the bone marrow transplant medical team provider buy-in of the project, it further 
supported having the primary nurse complete the algorithm.  By having the primary nurse 
complete the algorithm, it lessened the time burden on patient rounds, and consequently allowed 
the medical team to assess the algorithm score and determine whether a palliative care consult or 
other appropriate interventions were needed, with minimal interruption to the rounding culture.  
Patient Rounds.  Daily bone marrow transplant unit patient rounds include an attending 
physician, oncology fellow, advanced practice provider (nurse practitioners or physician 
assistant), pharmacist, charge nurse, primary nurse, social worker, and nutritionist.  Each patient 
is individually presented to and assessed by the bone marrow transplant interprofessional team, 
with all disciplines providing insight to the patient’s plan of care.  The patients with positively 
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screened algorithms and scores >5 were presented and reviewed during this time.  If a patient 
scored greater than five on the algorithm, the bone marrow transplant medical team considered a 
palliative care consult.  The medical team initiated the palliative care consult if a patient’s 
symptoms worsened after initial bone marrow transplant provider interventions or previous 
interventions were no longer working.  If the bone marrow transplant team did not initiate a 
palliative care consult, the reason was documented, in addition to what new interventions 
occurred.  Palliative care consults may not have occurred for various reasons including new 
interventions ordered by the bone marrow transplant team, awaiting results from previously 
ordered interventions, or patient/family refusal to have a palliative care consult.  
The project lead rounded bi-weekly with the medical team and was available to nursing 
staff to answer any questions or concerns regarding the algorithm and was available at other 
times by phone or email.  The project lead also intermittently completed algorithms, in addition 
to the ones completed by the nursing staff, to guarantee scoring was consistent among nursing 
staff.  A total of 36 randomly chosen algorithms were completed by the project lead and will be 
discussed in further detail later.  
Implementation Trial Period.  An initial three-week trial occurred of the project 
implementation allowing providers and nurses time to learn how to use the algorithm and 
provide feedback of the algorithm and implementation process.  This input was used to modify 
the algorithm to best meet the needs of the providers and nurses to promote successful 
completion of the project.  After completion of the project implementation, clinicians were 
surveyed again to provide feedback on the algorithm, gauging whether they found the algorithm 
useful, easy to use, and what (if any) parts of the algorithm they would modify. 
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The number of palliative care consults recorded during this three-month (12 week) 
project intervention time period were compared to the total number of palliative care consults 
that occurred over the prior five year (60 month) period, retrieved from the palliative care 
database.  As stated, the primary project goal was to determine whether palliative care consults 
increased after implementing the algorithm.  Results were evaluated by comparing the palliative 
care rates pre-and-post intervention.  
Feedback Survey.  A feedback survey was sent via email to all bone marrow transplant 
clinicians, three-weeks after the initial project implementation (presented in Appendix E) and 
again after completion of implementation (shown in Appendix F), asking for input on the ease of 
use of the algorithm tool, issues or concerns with project intervention, and what changes (if any) 
were needed.  The feedback was used to maintain stakeholder involvement and to also guarantee 
the algorithm and project were developed to include necessary bone marrow transplant patient 
symptom criteria.   
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CHAPTER 5: RESULTS 
Outcomes  
Algorithm Data.  During the three-month project implementation, 210 algorithms were 
completed in 38 patients on the inpatient bone marrow transplant unit.  It is important to note that 
bone marrow transplant inpatient hospital length of stays average 3-4 weeks.  Due to the 
extended length of time of an inpatient BMT admission, most patients were rescreened multiple 
times during their admission.  Hence why there are more algorithms completed (n=210) than 
patients screened (n=38).  Multiple screenings were appropriate as symptomology, interventions, 
and patient statuses change throughout a hospitalization for a bone marrow transplant.  Of the 
210 algorithms completed, 24 algorithms (11.43%) scored positively (> 5) (as shown in Table 1). 
Table 1. Inpatient BMT Algorithm Data (n = 210) 
 
Note: * 25% result = 6 total PC consults / 24 positively scored algorithm with score >5 
 
Patient Data.  Of the 38 patients screened in the 210 completed algorithms, eight scored 
positively on the palliative care consult algorithm (score >5) (21.05%) and four received 
palliative care consults (10.53%).  Two of the four patients consulted by palliative care were 
actually consulted twice during their bone marrow transplant admission due to increased and 
altered symptom presentation and burden.  This suggests there were actually six palliative care 
# %
Completed Algorithms 210 100%
Algorithms Scoring Total >5 24 11.43%
Algorithms Scoring Total <5 186 88.57%
Palliative Care Consults from Completed Algorithms 6 2.85%
Palliative Care Consults Resulted from Algorithms Scoring Total >5 6 *25%
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consults total during the implementation period since two of the four patients were consulted 
twice (as shown in Table 2). 
Table 2. Inpatient BMT Patients Screened Data (n = 38) 
 
 Note: BMT patients may not have been consulted by PC because they scored <5 on PC 
algorithm OR because the BMT team provided other symptom management interventions.  
 
Symptom Management Interventions 
Patients who screened positively on the algorithm (score >5) but did not receive a 
palliative care consult (4 patients) had varied interventions ordered by the BMT medical team 
(presented in Table 3).  Palliative care consults did not occur for four positively screened patients 
because of specific interventions listed below or because the bone marrow patient and family 
refused the option of a palliative care consult.  The interventions implemented by the bone 
marrow transplant team for the patients that scored >5 on the algorithm, but did not receive a 
palliative care consult included: 
• Added symptom management therapies including increasing / altering pain 
management regimen (4) 
• Initiated new anti-emetics not previously ordered (2) 
• Started scheduled anxiolytics (1) 
• Added an anti-depressant (1)  
• Considered additional oncologic treatment and/or second SCT (1) 
• Initiated high-dose steroids (2) 
• Ordered bowel rest (NPO dietary order) to help with diarrhea / gut GVH 
symptoms (1) 
# %
# BMT Patients Screened 38 100%
# BMT Patients Screened Positive (Score >5) 8 21.05%
# BMT Patients Consulted for Palliative Care Services 4 10.53%
# BMT Patients that Received Enhanced Symptom Mgmt from BMT team 13 34.21%
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• Referral to other supportive care services (3) 
• Discussed code status (1) 
• Evaluated goals of care (1) 
• Referral to hospice (1) 
Three patients were consulted to other supportive care services offered at the medical 
center, specifically the comprehensive cancer support program, which is separate from palliative 
care services.  Patients who scored positively on the algorithm and considered appropriate for a 
palliative care consult were educated of palliative care services by the bone marrow transplant 
medical team and their option to be consulted to the service.  Families and caregivers were also 
informed they could refuse a palliative care consult.  Two patients refused palliative care 
intervention, preferring to keep all symptom management care with the BMT medical team only.   
Table 3. Enhanced Symptom Management Interventions by BMT Team for Patients with 
Algorithm Scores >5 NOT Consulted for PC (n=4) 
 
Note: Some patients scoring >5 on algorithm NOT receiving PC scored >5 more than one time 
and necessitated multiple interventions from the BMT medical team. 
 
Of note, the number of interventions ordered by the inpatient bone marrow transplant 
medical team does not equal the number of positively screened algorithms as patients may score 
high enough on the palliative care algorithm to necessitate a consult but do not require additional 
interventions outside the specialized inpatient bone marrow transplant standard of care orders.  
Some side effects are anticipated throughout the bone marrow transplant process and “pro re 
Pain Intervention 4
Other Symptom Management Intervention (Anxiolytic, Antiemetic, Antidiarrheal) 4
BMT Specific Symptom Management (GVHD, CMV, etc) 3
Referral to Other Services 3
Family / Caregiver Refusal to Consult Palliative Care 2
Hospice Referral 1
Goals of Care Discussion 1
Further Oncologic Treatment 1
Code Status Discussion 1
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nata” (PRN or as needed) medications are already available to nursing to administer for symptom 
management as needed.  These medications are outlined specifically in the unique bone marrow 
transplant admission order set.  For the purpose of this project, these anticipated chemotherapy 
and transplant side effects, although distressing, did not necessitate further interventions by the 
bone marrow transplant medical team or suggest a palliative care consult. 
Statistical Significance Using Chi-Square Test 
As noted above, a total of six palliative care consults occurred on four different patients 
during this three-month (12 week) project implementation.  Previously, between the years of 
2010-2015 (60 months, 260 weeks), eight palliative care consults occurred, per the palliative care 
database.  From these results, it appears use of the inpatient palliative care consult algorithm 
increased the frequency and use of palliative care services.  However, these results must be 
further evaluated to determine whether the project intervention of implementing the palliative 
care algorithm for inpatient bone marrow transplant patients resulted in statistically significant 
results. 
The chi-square test was used to evaluate statistical significance between these two, 
independent comparison groups, at a 99% confidence interval (p = 0.01, z-score > 2.576).  The 
control group includes the total number of eligible inpatient bone marrow transplant patients who 
could have received a palliative care consult between the years 2010-2015.  A total of 802 
patients were transplanted during this 260-week period and were eligible for a palliative care 
consults while inpatient.  A total of eight palliative care consults occurred during this 260-week 
time period, as was determined from the palliative care database records.  The treatment group 
includes the total number of bone marrow patients that were admitted to the inpatient bone 
marrow transplant unit and were screened with the inpatient palliative care consult algorithm 
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during the three–month project implementation period.  A total of 38 patients were screened with 
the palliative care algorithm intervention, with a total of six palliative care consults occurring.  A 
computed z-statistic score of 6.9 resulted and provides statistically significant evidence at a 99% 
confidence interval (p = 0.01, z-statistic > 2.576) that the proportion of patients consulted for 
palliative care with clinician use of the palliative care consult algorithm differed from the 
proportion of patients who received palliative care consults without clinician use of the 
algorithm.  Therefore, it follows that use of the inpatient palliative care algorithm resulted in a 
statistically significant increase in palliative care consult rates, at a 99% confidence interval.  
Table 4. Chi-Square Test Comparing Control to Treatment Group 
 
Note: p-value = 0.01 (z-score = 6.9; statistically significant since z-score > 2.576) 
 
Algorithm Inter-Rater Reliability 
As previously stated, the project lead completed additional algorithms on patients already 
completed by the primary nurse, to guarantee scoring consistency and assess inter-rater 
reliability of the algorithm.  Of the 36 randomly chosen algorithms completed by the project 
lead, 34/36 or 94.4% were identical and 2 (5.6%) received different total scores, neither of which 
would have changed whether the algorithm scored > 5 or not, and would necessitate a palliative 
care algorithm.  The criteria where the variance occurred involved evaluating the distress score 
of the patient with the project lead scoring lower than the primary nurse.  Perhaps this was due to 
the primary nurse having direct contact with the patient and being more aware of their distress 
screening scoring. 
 
 
Control Group Treatment Group
(NO Algorithm Intervention) (Algorithm Intervention)
# Patients Eligible for PC Consult n=802 n=38
# PC Consults 8 6
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Survey Feedback 
The inpatient bone marrow transplant clinicians reported the algorithm was easily 
incorporated into their daily care and rounds.  During the initial meeting with the medical team, 
concerns arose about the length of time the algorithm would add to patient rounds.  From this, it 
was determined that nursing could screen the patients and provide the positively screened 
algorithms (those with scores >5) to the charge nurse to report to the bone marrow transplant 
medical providers during patient rounds.  This process allowed consistent use of the algorithm, 
encouraged nursing input on the patient status and symptomology, and permitted time for the 
providers to fully evaluate whether a palliative care consult was necessary.   
Of note, algorithm implementation and total completion time was not listed as a 
hindrance from the surveyed feedback obtained after the projection completion.  On the post-
implementation follow-up survey, medical providers noted discussion of the algorithm added 
approximately one minute to patient rounds and nurses reported the algorithm took three minutes 
per patient to complete.  
After completion of the 12-week intervention, both clinician groups reported on the 
follow-up survey that the algorithm did not obstruct their care process or work flow.  Nurses 
reported the algorithm could easily be incorporated into their clinical practice and felt it was 
beneficial for patients.  They acknowledged it allowed an opportunity for them to initiate 
conversations regarding palliative care with the bone marrow transplant medical team, when they 
had been hesitant to discuss this topic before.  In regard to the algorithm, there were no consult 
criterion that clinicians would have removed or added outside what was already included, giving 
the measure face validity.  Perhaps this was due to having stakeholder input prior to creating the 
algorithm and throughout the project implementation.  
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CHAPTER 6: DISCUSSION 
Discussion 
Consult Data. Overall, use of the palliative care algorithm for inpatient bone marrow 
transplant patients increased the number of palliative care consults compared to previous years.  
The use of the palliative care consult algorithm resulted in six palliative care consults in four 
patients during the three-month period implementation, and also determined specific 
interventions for those not receiving a consult (4 patients scoring >5).   
Stakeholder Involvement.  Obtaining stakeholder involvement from the initial 
formation of the algorithm and obtaining buy-in was imperative to the successful completion of 
this project.  Prior to project implementation, all clinicians had the opportunity to offer input to 
the algorithm development, either via email or during in-person meetings and discussions of this 
project and algorithm.  Clinicians could also offer suggested changes to the algorithm and 
implementation process up to three-weeks after project initiation, and then again after 
completion of the twelve-week project implementation via the feedback surveys.  Having 
frequent stakeholder input fostered continued buy-in and may encourage future use of the 
algorithm as part of clinical practice, even after project completion.  
Further Education / Clarification.  Throughout the intervention period, further 
clarification or education for the stakeholders was needed.  The project lead re-educated the 
medical staff, primary nurses, and charge nurses of the project implementation guidelines and 
scoring criteria to guarantee all staff were aware of how and when the algorithm needed to be 
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completed.  Clarification was needed to further explain the screening tools (Karnofsky, ECOG, 
NCCN Distress Screening) that were part of the algorithm.  Additionally, nurses often needed 
reminders when to complete the algorithm since it was done bi-weekly.   
Unfortunately, there was one shift when every nurse forgot to complete the algorithm on 
its scheduled day.  Consequently, email reminders were again added on nights the algorithm was 
to be completed.  Additionally, reminder notes were made to the nursing charge report sheet to 
prompt charge nurses and nursing staff of when to complete the algorithm.  These algorithm 
reminder interventions improved the forgetfulness issue and allowed algorithms to be completed 
as scheduled.  Nurses reported it took approximately six weeks for the algorithm completion to 
be better remembered and become part of their routine care without needing reminders.   
Nurses also noted misunderstandings of what to do with positively screened algorithms 
and / or did not always communicate with charge nurses which patients screened positively.  
Some nurses gave the completed forms directly to the bone marrow transplant medical team, 
whether the patient screened positive or not, while others filed all algorithms where the blank 
algorithms were stored, assuming the charge nurse retrieved them.  Further education by the 
project lead during staff meetings and nursing huddles again reminded nurses to give only 
positively screened algorithms to the charge nurse so these could be presented during rounds and 
to keep all other algorithms for data collection.  Although the confusion of what to do with 
completed algorithms improved throughout the implementation period, nurses frequently needed 
reminders of this procedural step of the project.  
Limitations 
 Limitations of the project include that during the intervention time period, the bone 
marrow transplant patient census on this particular unit was less than anticipated due to 
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organizational restructuring and openings of other bone marrow transplant units in the region.  
The decreased patient census resulted in fewer algorithms completed and fewer patients assessed 
during the project implementation.  Perhaps a longer intervention time period where more 
patients could be accrued would yield different results.   
 Patient outcomes and symptom management outcomes were also not measured with this 
QI project.  Due to the focus of this project implementation and project aims, patient outcomes 
were not measured.  It would be of interest to assess whether use of this consult algorithm and 
increased focus on symptom management by clinicians impacted patient’s overall outcomes.   
Additionally, the inpatient bone marrow transplant clinicians and other stakeholders 
understood the number of palliative care consultations were being audited by the project lead.  
This may have led to more consults occurring than would have been done normally.  The 
Hawthorne effect, where behavior alterations by the subjects of a study occur due to their 
awareness of being observed, must be considered as to whether more palliative care consults 
occurred as a result of using the algorithm or because of the nurses and providers’ awareness of 
this QI project and professional relationship with project lead.  
Finally, although a single-site project location is the purpose of a DNP project, it would 
be of interest to gauge whether the algorithm implementation presents similar results in other 
bone marrow transplant settings. 
Recommendations 
Recommendations for future practice include implementing the algorithm on other bone 
marrow transplant units and evaluating whether results are reproducible or similar.  As stated, 
this quality improvement project occurred on a single bone marrow transplant unit.  Use of the 
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palliative care consult algorithm should be further implemented at other centers to evaluate 
outcomes and consequent palliative care consult rates.  
Additionally, bone marrow transplant clinician input should continue to be assessed to 
further determine whether other aspects of bone marrow transplant patient care criteria should be 
included or removed from the algorithm.  Other centers may consider alternate bone marrow 
transplant patient care criteria not included in this algorithm.   
Enhanced Symptom Management.  Furthermore, use of the algorithm proved to initiate 
symptom management discussions of bone marrow transplant patients and implementation of 
interventions by the medical team.  Additional projects could evaluate whether algorithm use 
increased the number of symptom management interventions overall for patients, in addition to 
the number of palliative care consults.  Additionally, some patients that did not score positively 
(score <5) on the algorithm (n=13 patients) still received additional symptom management 
interventions by the bone marrow transplant medical team because of certain positive algorithm 
criteria (presented in Table. 2).  Although these patients did not screen positively on the 
algorithm (score >5) for a palliative care consult, the individual criteria in which they accrued 
points suggested to the bone marrow transplant team an intervention was needed.  These 
enhanced symptom management interventions occurred because of the algorithm criteria scoring 
discussions that occurred between clinicians.  This suggests that increased attention was placed 
on symptom management, not only for patients scoring positively on the algorithm (score >5) 
and not receiving consults (n=4), but also for patients scoring <5 on the algorithm who needed 
additional symptom management.  The specific interventions for algorithms scoring <5 were not 
recorded for this project since this project specified interventions were only to be recorded for 
those patients screening positively on the algorithm (>5), but not receiving palliative care 
 38 
consults.  However, these patients are mentioned to suggest use of the algorithm potentially 
fostered additional symptom management interventions for bone marrow transplant patients by 
the medical team, even if they did not screen positively for potential palliative care consults.  
Validity and Reliability.  Additionally, future projects should implement this algorithm 
with greater subject numbers to test its validity and reliability.  Validity and reliability testing of 
this novel algorithm specific to bone marrow transplant patients should be formally evaluated to 
allow for future use in multiple settings.  Since this was the initial trial of the algorithm, it 
follows that additional testing and validation is necessary. 
Clinical Practice Recommendations.  Recommendations for improving the process of 
the algorithm clinical process implementation include having reminders on each patient report 
sheet to signal nurses when to complete the algorithm, so it is not missed.  Another 
recommendation would be to incorporate the algorithm into electronic medical charting systems 
to allow prompts to appear for nursing to complete the algorithm and so that providers can 
readily access the algorithm scoring.  This electronic medical record access would expedite the 
algorithm scoring reporting and potentially accelerate palliative care consults, as all information 
on the palliative care algorithm would be readily available.  
Conclusion 
 Palliative care provides a specialized consult service to help patients manage their disease 
symptoms, plan for their future treatment and goals, and improve their overall quality of life.  A 
gap currently exists between the documented evidence supporting use of palliative care in 
clinical oncology practice and its implementation in patient care.  Although the evidence and 
clinical practice guidelines support use of palliative care for appropriate patients, the service is 
still underutilized.   
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Quality improvement projects, such as this, must continue to occur to improve use of this 
service.  The development and implementation of this palliative care consult algorithm for 
inpatient bone marrow transplant patients provides objective criteria for providers to initiate 
palliative care consults or to refocus on symptom management.  As mentioned, the primary 
objective of this project was to develop a tool that could be easily used by bone marrow 
transplant clinicians to determine potential patients appropriate for palliative care consults in the 
inpatient bone marrow transplant setting.   
As shown, the number of palliative care consults that occurred during this project 
implementation period resulted in a statistically significant increase in palliative care consults 
compared to previous consult data.  A secondary outcome documented the unique interventions 
recommended by the primary bone transplant medical team specific for bone marrow transplant 
patients’ symptoms.  These interventions were recorded to present the specialized interventions 
used by the bone marrow transplant medical team and possibly explain the underutilization of 
palliative care consults for this unique service line.  Awareness of these specific interventions 
can provide insight to the interventions used by this specialized service and ways bone marrow 
transplant providers manage their patients’ symptom burden currently.  The outcomes and data 
collected from this quality improvement project present a novel palliative care algorithm tool for 
bone marrow transplant providers and also provide awareness on the specialized interventions 
used by the bone marrow transplant medical team.  Together, these outcomes could help increase 
utilization of palliative care consult services and present the particular interventions needed for 
this unique patient population. 
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APPENDIX A: THEORETICAL APPROACH – BRONFENBRENNER’S ECOLOGICAL 
SYSTEMS THEORY 
 
 
 
 
 
 
 
Pollack, D. (2015). Bronfenbrenner: Ecologic Systems Theory [Diagram]. Retrieved from  
https://www.cheatography.com/davidpol/cheat-sheets/bronfenbrenner-ecological-
systems-theory/pdf/. 
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APPENDIX B: PALLIATIVE CARE CONSULT ALGORITHM FOR INPATIENT BONE 
MARROW TRANSPLANT PATIENTS – DRAFT 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BMTU%Inpatient%Palliative%Care%Algorithm%
Date:&
&
Room&#:&
&
&
Initial&BMT&consult&within&previous&4&months?&(1#point)#______________&
&
Functional&status&of&patient&(Karnofsky&Performance&Scale)*&(0+2#points)#______________&
&
Serious&transplantGrelated&complications&(hemorrhagic&cystitis,&GVHD&–&grade&IV,&VOD,&CMV,&BK)&(2#points)#______________&
&
Significant&physical&/&psychosocial&comorbidities&(i.e.,&depression,&anxiety,&HTN,&DM,&COPD,&CKD)&(1#point)#______________&
&
Other&issues&complicating&care&(1#point)#______________&
&
Uncontrolled&symptoms&(pain,&n/v)&(1#point)#______________&
&
ModerateGtoGsevere&distress&related&to&cancer&diagnosis&and&treatment&(1#point)#______________&
&
Patient&/&family&concerns&related&to&care&/&decisionGmaking&(1#point)#______________&
&
Patient&/&family&requests&consult&(5#points)#______________&
#
Prolonged&length&of&hospital&stay&(>1&month)&(1#point)#______________&
&
Frequent&readmissions&(>1&since&BMT&discharge)&(1#point)#______________&
&
&
Total&score:&&#########/17####&(>&5&suggests&palliative&care&consult)&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&Palliative&Care&Consult&Ordered?&(Circle&one)&&&Y&&/&&&N&
&
If&consult&not&initiated,&please&explain&what&interventions&occurred:&
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APPENDIX C: PALLIATIVE CARE CONSULT ALGORITHM FOR INPATIENT BONE 
MARROW TRANSPLANT PATIENTS – DRAFT 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BMTU%Inpatient%Palliative%Care%Algorithm%
Date:& & & & & & & & & & & & Completed&by:&
&
Room&#:& & & & & & & & & & & Attending&on&service:&
&
&
Initial&BMT&consult&within&previous&4&months?&& & & & & & & & (1#point)#########_________#&
&&
Functional&status&of&patient&(Karnofsky&Performance&Scale/ECOG)& & & & & & (0,2#points)####_________#&
(Grade'80*100:'0'points,'Grade'60*79:'1'point,'Grade'<60:'2'points)& & & & & &
&
Serious&transplantNrelated&complications&(hemorrhagic&cystitis,&GVHD&–&grade&IV,&VOD,&CMV,&BK)&& (2#points)########_________#&
&
Significant&physical&/&psychosocial&comorbidities&(i.e.,&depression,&anxiety,&HTN,&DM,&COPD,&CKD)&& (1#point)##########_________#&
&
Other&issues&complicating&care&(financial&concerns,&lack&of&support)& & & & & (1#point)##########_________#&
&
Uncontrolled&symptoms&(pain,&n/v/d,&constipation)&&& & & & & & & (1#point)##########_________#&
&
ModerateNtoNsevere&distress&related&to&cancer&diagnosis&and&treatment&& & & & & (1#point)##########_________#&
NCCN&Cancer&distress&screening&score&>6&=&1&point& & & & & &
&
Patient&/&family&concerns&related&to&care&/&decisionNmaking&& & & & & & (1#point)##########_________#&
&
Patient&/&family&requests&consult&& & & & & & & & & & (5#points)########_________#&
#
Prolonged&length&of&hospital&stay&(>1&month)&& & & & & & & & (1#point)##########_________#&
&
Frequent&readmissions&(>1&since&BMT&discharge)&& & & & & & & & (1#point)&&&&&&&&&&_________#&
&
Total&score:&&#############&(>&5&suggests&palliative&care&consult)&&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
Palliative&Care&Consult&Ordered?&(Circle&one)&&&Y&&/&&&N&
&
If&consult&not&initiated,&please&explain&what&interventions&occurred:&
 43 
APPENDIX D: PALLIATIVE CARE CONSULT ALGORITHM FOR INPATIENT BONE 
MARROW TRANSPLANT PATIENTS – FINAL DRAFT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BMTU%Inpatient%Palliative%Care%Algorithm%
Date:& & & & & & & & & & & & Completed&by:&
&
Room&#:& & & & & & & & & & & Attending&on&service:&
&
&&
Functional&status&of&patient&(Karnofsky&Performance&Scale/ECOG)& & & & & & (0#2%points)%%%%_________%&
(Grade'80*100:'0'points,'Grade'60*79:'1'point,'Grade'<60:'2'points)& & & & & &
&
Serious&transplantFrelated&complications&(hemorrhagic&cystitis,&GVHD&–&grade&IV,&VOD,&CMV,&BK)&& (2%points)%%%%%%%%_________%&
&
Significant&physical&/&psychosocial&comorbidities&(i.e.,&depression,&anxiety,&HTN,&DM,&COPD,&CKD)&& (1%point)%%%%%%%%%%_________%&
&
Other&issues&complicating&care&(financial&concerns,&lack&of&support)& & & & & (1%point)%%%%%%%%%%_________%&
&
Uncontrolled&symptoms&(pain,&n/v/d,&constipation)&&& & & & & & & (1%point)%%%%%%%%%%_________%&
&
ModerateFtoFsevere&distress&related&to&cancer&diagnosis&and&treatment&& & & & & (1%point)%%%%%%%%%%_________%&
NCCN&Cancer&distress&screening&score&>4&=&1&point& & & & & &
&
Patient&/&family&concerns&related&to&care&/&decisionFmaking&& & & & & & (1%point)%%%%%%%%%%_________%&
&
Patient&/&family&requests&consult&& & & & & & & & & & (5%points)%%%%%%%%_________%&
%
Prolonged&length&of&hospital&stay&(>1&month)&& & & & & & & & (1%point)%%%%%%%%%%_________%&
&
Frequent&readmissions&(>1&since&BMT&discharge)&& & & & & & & & (1%point)&&&&&&&&&&_________%&
&
Total&score:&&%%%%%%%%%%%%%&(>&&5&suggests&palliative&care&consult)&&
&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
Palliative&Care&Consult&Ordered?&(Circle&one)&&&Y&&/&&&N&
&
If&consult&not&initiated,&please&explain&what&interventions&occurred:&
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APPENDIX E: 3-WEEK TRIAL FOLLOW-UP SURVEY FOR BMT CLINICIANS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3-Week Trial Survey of the Palliative Care Algorithm for Inpatient BMT Patients
Please answer the following questions.
Is the algorithm user-friendly?
How long does it take to complete the algorithm?
How much time was added (per patient) to discuss the algorithm during rounds?
Should other criteria be included?
Should other criteria be deleted / excluded?
Any other changes / recommendations / adjustments for the algorithm?
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APPENDIX F: POST-IMPLEMENTATION FOLLOW-UP SURVEY FOR BMT CLINICIANS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Post-Intervention Survey of the Palliative Care Algorithm for Inpatient BMT Patients
Please answer the following questions.
Was the algorithm user-friendly?
Could / would you incorporate this algorithm into your clinical practice?
How long did it take to complete the algorithm?
How much time was added (per patient) to discuss the algorithm during rounds?
Should other specific BMT patient criteria be included?
Should other criteria be deleted / excluded?
Any other changes / recommendations / adjustments for the algorithm?
Any other changes / recommendations for the algorithm implementation process?
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